Ethacridine

DB13190InvestigationalSmall molecule

Ethacridine: Overview.

Chemical structure of Ethacridine
Formula / weight
C15H15N3O · 253.305 g/mol (avg)

Resolves to

Compound
UNIIWIX85M1A6RCAS442-16-0ChEMBLCHEMBL94007ChEBI135032
Clinical / RWD
RxNorm4106ATCB05CA08ATCD08AA01
Structure
InChIKeyCIKWKGFPFXJVGW-UHFFFAOYSA-NSMILESCCOC1=CC2=C(NC3=C(C=CC(N)=C3)C2=N)C=C1
Targets
Q13639HTR4Q86W56PARG

What you can answer from here — as of September 25, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
1Clinical trialPhase, status and sponsor resolved per trial
Sign in
1Structured indicationCondition, population, route and combination as fields, not prose
Sign in
3Marketed productsAcross 1 country and 2 labellers
Sign in
2ATC codesIncluding every combination product, plus 11 drug categories
Sign in
7+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Ethacridine, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In